MTHFR gene polymorphism and severe toxicity during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil (CMF)

This publication has 5 references indexed in Scilit:

• Homocyst(e)ine and Cardiovascular Disease: A Critical Review of the Epidemiologic Evidence
  Annals of Internal Medicine, 1999
• Mortality during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil
  The Lancet, 1999
• A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells
  Proceedings of the National Academy of Sciences, 1998
• Polychemotherapy for early breast cancer: an overview of the randomised trials
  The Lancet, 1998
• A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase
  Nature Genetics, 1995